In January, Revolution Medicines was rumored to have a $30 billion buyout offer on the table. Now, it doesn’t.
Also in January, Revolution didn’t have its Phase 3 pancreatic cancer results. Now, it does.
So …
OpenAI is launching ChatGPT for Clinicians, a free tool for doctors, nurse practitioners, physician assistants and pharmacists. It’s the latest product the AI giant has
AbbVie has provided new details about its $100 billion pledge to the US, budgeting $1.4 billion for its first manufacturing campus in North Carolina. Construction
MSD has agreed a deal with Google Cloud that will put the tech giant’s AI tools in the hands of its 75,000 employees worldwide.
BridgeBio Oncology Therapeutics is replacing CEO Eli Wallace, putting its CSO Pedro Beltran in the role, and making board member Neil Kumar executive chairman. The
The FDA for the first time is facing pharma-backed criticism of its new practice of publicly releasing partially redacted drug rejection letters. The law firm
In January, Revolution Medicines was rumored to have a $30 billion buyout offer on the table. Now, it doesn’t.
Also in January, Revolution didn’t have its Phase 3 pancreatic cancer results. Now, it does.
So …